These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25384074)

  • 21. A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
    Rascol O; Lees AJ; Senard JM; Pirtosek Z; Brefel C; Montastruc JL; Fuell D
    Adv Neurol; 1996; 69():531-4. PubMed ID: 8615176
    [No Abstract]   [Full Text] [Related]  

  • 22. Recruitment of additional brain regions to accomplish simple motor tasks in chronic alcohol-dependent patients.
    Parks MH; Greenberg DS; Nickel MK; Dietrich MS; Rogers BP; Martin PR
    Alcohol Clin Exp Res; 2010 Jun; 34(6):1098-109. PubMed ID: 20374203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
    Kim HJ; Park SY; Cho YJ; Hong KS; Cho JY; Seo SY; Lee DH; Jeon BS
    J Neurol Sci; 2009 Dec; 287(1-2):200-4. PubMed ID: 19700173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease.
    Dusek P; Busková J; Růzicka E; Majerová V; Srp A; Jech R; Roth J; Sonka K
    Clin Neuropharmacol; 2010 Jul; 33(4):186-90. PubMed ID: 20661025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topographic pattern of cortical thinning with consideration of motor laterality in Parkinson disease.
    Kim JS; Yang JJ; Lee JM; Youn J; Kim JM; Cho JW
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1186-90. PubMed ID: 25231669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ropinirole in the symptomatic treatment of Parkinson's disease.
    Brooks DJ; Torjanski N; Burn DJ
    J Neural Transm Suppl; 1995; 45():231-8. PubMed ID: 8748630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
    Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic modulation of cortico-cortical functional connectivity in Parkinson's disease: an MEG study.
    Stoffers D; Bosboom JL; Wolters ECh; Stam CJ; Berendse HW
    Exp Neurol; 2008 Sep; 213(1):191-5. PubMed ID: 18590728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of two different dopamine agonists in the management of Parkinson's disease.
    Stocchi F; Berardelli A; Vacca L; Thomas A; De Pandis MF; Modugno N; Valente M; Ruggieri S
    Neurol Sci; 2002 Sep; 23 Suppl 2():S115-6. PubMed ID: 12548370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levodopa-induced striatal activation in Parkinson's disease: a functional MRI study.
    Kraft E; Loichinger W; Diepers M; Lule D; Schwarz J; Ludolph AC; Storch A
    Parkinsonism Relat Disord; 2009 Sep; 15(8):558-63. PubMed ID: 19467909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of high-frequency repetitive transcranial magnetic stimulation over ipsilesional primary motor cortex in cortical and subcortical middle cerebral artery stroke.
    Ameli M; Grefkes C; Kemper F; Riegg FP; Rehme AK; Karbe H; Fink GR; Nowak DA
    Ann Neurol; 2009 Sep; 66(3):298-309. PubMed ID: 19798637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracerebral ERD/ERS in voluntary movement and in cognitive visuomotor task.
    Rektor I; Sochůrková D; Bocková M
    Prog Brain Res; 2006; 159():311-30. PubMed ID: 17071240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.
    Korczyn AD; Brooks DJ; Brunt ER; Poewe WH; Rascol O; Stocchi F
    Mov Disord; 1998 Jan; 13(1):46-51. PubMed ID: 9452325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs of control: decreased motor cortex engagement during a Go/NoGo task in Tourette's syndrome.
    Thomalla G; Jonas M; Bäumer T; Siebner HR; Biermann-Ruben K; Ganos C; Orth M; Hummel FC; Gerloff C; Müller-Vahl K; Schnitzler A; Münchau A
    Brain; 2014 Jan; 137(Pt 1):122-36. PubMed ID: 24176975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.
    Schrag AE; Brooks DJ; Brunt E; Fuell D; Korczyn A; Poewe W; Quinn NP; Rascol O; Stocchi F
    Clin Neuropharmacol; 1998; 21(3):169-75. PubMed ID: 9617508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ropinirole on visuo-motor test in newly diagnosed Parkinson's disease patients.
    Badarny S; Stern A; Susel Z; Honigman S; Hocherman S
    Acta Neurol Scand; 2006 May; 113(5):294-300. PubMed ID: 16629764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.
    Herz DM; Siebner HR; Hulme OJ; Florin E; Christensen MS; Timmermann L
    Neuroimage; 2014 Apr; 90():15-23. PubMed ID: 24269570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine agonists in the treatment of Parkinson's disease.
    Bonuccelli U; Pavese N
    Expert Rev Neurother; 2006 Jan; 6(1):81-9. PubMed ID: 16466315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the supplementary motor area in the automatic activation of motor plans in de novo Parkinson's disease patients.
    D'Ostilio K; Deville B; Cremers J; Grandjean J; Skawiniak E; Delvaux V; Garraux G
    Neurosci Res; 2013 Jul; 76(3):173-7. PubMed ID: 23643464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cluster-based quantitative procedure in an fMRI study of Parkinson's disease.
    Macrì MA; Garreffa G; Giove F; Moraschi M; Giulietti G; Modugno N; Colonnese C; Maraviglia B
    Magn Reson Imaging; 2006 May; 24(4):419-24. PubMed ID: 16677948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.